Company Overview
Glaxosmithkline Trading Services Limited is listed at the official companies registry as Active Overseas Company. The company was incorporated on Friday 31 May 2013, so this is a well established company. Glaxosmithkline Trading Services Limited has been in business for 12 years and 10 months. The accounts status is full.
Registered Address

12 Riverwalk, Citywest Business Campus, Dublin, 24
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameGLAXOSMITHKLINE TRADING SERVICES LIMITED
Company NumberFC031402
Registered Office Address12 Riverwalk
 Citywest Business Campus
Company CategoryOverseas Company
Company StatusActive
Country of OriginIRELAND
Incorporation Date31/05/2013
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryFULL
Directors & Members
Show Resigned
Andrew Collier - Director
(British, 60 years old, born September 1966)
Appointed 01 January 2025
 Active
Simon Lund - Director
(British, 55 years old, born March 1971)
Appointed 13 January 2026
 Active
Aidan Lynch - Director
(Irish, 62 years old, born February 1964)
Appointed 06 February 2019
 Active
Yvonne Stewart - Director
(British, 53 years old, born October 1973)
Appointed 13 September 2021
 Active
Neil Wilkinson - Director
(British, 50 years old, born July 1976)
Appointed 01 November 2024
 Active
Edinburgh Pharmaceutical Industries Limited - Secretary
Appointed 21 June 2013
 Active
Secretaries
Victoria Whyte - Secretary
Appointed 21 June 2013
 Active
Edinburgh Pharmaceutical Industries Limited - Secretary
Appointed 21 June 2013
 Active
Other Company Directorships
Andrew Collier
No companies found
Simon Lund
No companies found
Aidan Lynch
GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO 3) LIMITED
GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO.2) UNLIMITED COMPANY
GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) LIMITED
GLAXOSMITHKLINE CONSUMER HEALTHCARE IRELAND IP LIMITED
GLAXOSMITHKLINE EXPORT LIMITED
GLAXOSMITHKLINE INVESTMENTS (IRELAND) LIMITED
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
GLAXOSMITHKLINE US TRADING LIMITED
HALEON UK EXPORT LIMITED
HALEON UK TRADING LIMITED
HALEON UK TRADING SERVICES LIMITED
VIIV HEALTHCARE TRADING SERVICES UK LIMITED
Yvonne Stewart
GLAXOSMITHKLINE US TRADING LIMITED
Neil Wilkinson
GLAXOSMITHKLINE US TRADING LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2013
Balance Sheet
Fixed Assets 26,859,000,000 26,859,000,000
Current Assets 15,227,000,000 15,227,000,000
Creditors Due Within One Year 13,677,000,000 13,677,000,000
Working Cap 1,550,000,000 1,550,000,000
Total Assets Less Current Liabilities 28,409,000,000 28,409,000,000
Long-term Liabilities 21,412,000,000 21,412,000,000
Net Assets 6,997,000,000 6,997,000,000
Share Capital & Reserves
Share Cap 1,336,000,000 1,336,000,000
Profit & Loss Reserves 913,000,000 913,000,000
Other Reserves 4,748,000,000 4,748,000,000
Shareholders Funds 6,997,000,000 6,997,000,000
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2013
Tangible Fixed Assets - -
Fixed Assets 63.8% 63.8%
Stocks Inventory 9.3% 9.3%
Debtors 9.4% 9.4%
Cash Bank In Hand 13.1% 13.1%
Current Assets 36.2% 36.2%
Creditors Due Within One Year 32.5% 32.5%
Net Current Assets Liabilities 3.7% 3.7%
Creditors Due After One Year 50.9% 50.9%
Accruals Deferred Income - -
Provisions For Liabilities Charges - -
Net Assets Liabilities Including Pension Asset Liability 16.6% 16.6%
Called Up Share Capital 3.2% 3.2%
Share Capital Allotted Called Up Paid 3.2% 3.2%
Profit Loss Account Reserve 2.2% 2.2%
Shareholder Funds 16.6% 16.6%
Capital Employed - -
Total Assets Less Current Liabilities 67.5% 67.5%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2013
Liquidity Ratio 1.1 1.1
Solvency Ratio 1.2 1.2
Reserves to Assets 0.0 0.0
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2013
Assets 42,086,000,000 42,086,000,000
Debt 35,089,000,000 35,089,000,000
Net Assets/Debt 6,997,000,000 6,997,000,000

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The current section of the balance sheet has positive working capital. We would normally consider this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet this level of net assets suggests total debts and obligations were moderately well covered.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The current section of the balance sheet has positive working capital. We would normally consider this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet this level of net assets suggests total debts and obligations were moderately well covered.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The current section of the balance sheet has positive working capital. We would normally consider this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet this level of net assets suggests total debts and obligations were moderately well covered.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around
DURROCOAT LIMITED
UNIT 1 UNIT 1 COACHING HOUSE, CORNFORD ROAD, BLACKPOOL, LANCASHIRE
LEISURE EFFICIENCY LIMITED
C/O Foresight Group Llp The Shard, 32 London Bridge Street, London
MAIA REAL ESTATE LIMITED
Fairways House Links Business Park, Fortran Road, St. Mellons, Cardiff
SHEEP FREE PRODUCTIONS LIMITED
12 DE MONTFORT ROAD, READING, BERKSHIRE
ELTANIN LSPV LTD
3rd Floor Marthas Vineyard, Prince Consort Road, Hebburn, Tyne And Wear
DIADEM LSPV LTD
3rd Floor Marthas Vineyard, Prince Consort Road, Hebburn, Tyne And Wear
THE RESULTS FACTORY LIMITED
27 Julia Mcdaid, 27 Old Gloucester Street, London
LIME 'IN' LIMITED
UNIT G2-G7 BOW WHARF, GROVE ROAD, BOW, LONDON E3
W FLEMING INSPECTION SERVICES LIMITED
32-36 Chorley New Road, Bolton, Lancashire
ADS VENTURES LTD
Linen Hall Suite 540, Linen Hall, 162-168 Regent Street, London
Document Filings
Appointment of Simon David Lund as a director on 13 January 2026
Termination of appointment of Mark James Heathcote as a director on 13 January 2026
Secretary's details changed for Victoria Anne Whyte on 14 August 2025
Director's details changed for Dr Yvonne Margaret Stewart on 14 August 2025
Director's details changed for Mr Aidan Lynch on 14 August 2025
Director's details changed for Mr Mark James Heathcote on 14 August 2025
Appointment of Andrew James Collier as a director on 1 January 2025
Termination of appointment of Wendy Adams as a director on 31 December 2024
Appointment of Neil Richard Wilkinson as a director on 1 November 2024
Termination of appointment of Gabriel Millan as a director on 1 November 2024
Details changed for a UK establishment - BR016469 Address Change 980 great west road, brentford, middlesex, TW8 9GS,11 September 2024
Appointment of Gabriel Millan as a director on 13 December 2023
Termination of appointment of Jonathan Wilson Box as a director on 13 December 2023
Director's details changed for Ms Wendy Adams on 2 November 2022
Termination of appointment of Benoît Alsteens as a director on 13 September 2021
Appointment of Yvonne Stewart as a director on 13 September 2021
Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 1 January 2021
Details changed for an overseas company - Change in Accounts Details Ec
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free